Condition
Guillain-Barre Syndrome clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Guillain-Barre Syndrome clinical trials that are recruiting, at sites in 8 countries (most in Denmark (1), France (1), Spain (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 8Countries
Newest Guillain-Barre Syndrome clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Tanruprubart (ANX005) treatment for Guillain-Barré syndrome (FORWARD) | Phase 3 | Phoenix, Arizona and 29 other locations | Recruiting | Jun 13, 2025 |
| Breathing support options for adults with Guillain-Barré respiratory failure | — | Asyut, Assuit and 1 other locations | Recruiting | May 30, 2025 |
| Comparing early and late tracheostomy in patients with Guillain-Barre syndrome | — | Kfar Saba | Recruiting | Sep 25, 2024 |
| Identifying biomarkers for autoimmune diseases affecting the nervous system | — | Wuhan | Recruiting | Jul 15, 2024 |
All recruiting trials (4)
-
Tanruprubart (ANX005) treatment for Guillain-Barré syndrome (FORWARD)
This study will test tanruprubart (ANX005) in adults and children with recent-onset Guillain-Barré syndrome to see if it is safe, how the drug behaves in the body, and whether it helps recovery.
-
Breathing support options for adults with Guillain-Barré respiratory failure
This will test whether high-velocity nasal cannula or bi-level noninvasive ventilation works better for adults with Guillain-Barré syndrome who have severe breathing problems.
-
Comparing early and late tracheostomy in patients with Guillain-Barre syndrome
This study is testing if doing a tracheostomy sooner rather than later can help patients with Guillain-Barre syndrome who need breathing support recover faster and have better outcomes.
-
Identifying biomarkers for autoimmune diseases affecting the nervous system
This study is trying to find specific markers in the blood of people with autoimmune diseases affecting the nervous system, like Multiple Sclerosis, to help with early diagnosis and better treatment options.
Related topics
Quick answers
How many Guillain-Barre Syndrome clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in Denmark (1 trial), France (1 trial), Spain (1 trial), United Kingdom (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.